F. Sellebjerg
University of Copenhagen and Danish MS Research Center
Department of Neurology
Copenhagen University Hospital Rigshospitalet
Copenhagen
Denmark
Name/email consistency: high
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Sellebjerg, F., Börnsen, L., Khademi, M., Krakauer, M., Olsson, T., Frederiksen, J.L., Sørensen, P.S. Neurology (2009)
- Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation. Sellebjerg, F., Krakauer, M., Hesse, D., Ryder, L.P., Alsing, I., Jensen, P.E., Koch-Henriksen, N., Svejgaard, A., Soelberg Sørensen, P. Eur. J. Neurol. (2009)
- Gene expression analysis of interferon-beta treatment in multiple sclerosis. Sellebjerg, F., Datta, P., Larsen, J., Rieneck, K., Alsing, I., Oturai, A., Svejgaard, A., Soelberg Sørensen, P., Ryder, L.P. Mult. Scler. (2008)
- Chemokine receptor CCR5 in interferon-treated multiple sclerosis. Sellebjerg, F., Kristiansen, T.B., Wittenhagen, P., Garred, P., Eugen-Olsen, J., Frederiksen, J.L., Sørensen, T.L. Acta Neurol. Scand. (2007)
- CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis. Sellebjerg, F., Ross, C., Koch-Henriksen, N., Sørensen, P.S., Frederiksen, J.L., Bendtzen, K., Sørensen, T.L. Mult. Scler. (2005)
- EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Sellebjerg, F., Barnes, D., Filippini, G., Midgard, R., Montalban, X., Rieckmann, P., Selmaj, K., Visser, L.H., Sørensen, P.S. Eur. J. Neurol. (2005)
- Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis. Sellebjerg, F., Jensen, C.V., Larsson, H.B., Frederiksen, J.L. Mult. Scler. (2003)
- Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Sellebjerg, F., Sørensen, T.L. Brain Res. Bull. (2003)
- Cerebrospinal fluid levels of nitric oxide metabolites predict response to methylprednisolone treatment in multiple sclerosis and optic neuritis. Sellebjerg, F., Giovannoni, G., Hand, A., Madsen, H.O., Jensen, C.V., Garred, P. J. Neuroimmunol. (2002)
- Expansion of CD5 - B cells in multiple sclerosis correlates with CD80 (B7-1) expression. Sellebjerg, F., Jensen, J., Jensen, C.V., Wiik, A. Scand. J. Immunol. (2002)
- CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. Sellebjerg, F., Madsen, H.O., Jensen, C.V., Jensen, J., Garred, P. J. Neuroimmunol. (2000)
- HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis. Sellebjerg, F., Jensen, J., Madsen, H.O., Svejgaard, A. Tissue. Antigens (2000)
- Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis. Sellebjerg, F., Christiansen, M., Jensen, J., Frederiksen, J.L. Eur. J. Neurol. (2000)
- Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis. Sellebjerg, F., Jensen, C.V., Christiansen, M. J. Neuroimmunol. (2000)
- A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis. Sellebjerg, F., Nielsen, H.S., Frederiksen, J.L., Olesen, J. Neurology (1999)









